Highlighting the importance of this pathway in tumor immunity is the loss of WDFY4, a BEACH-domain containing protein essential for cross-presentation in conventional DCs, which results in failure to both prime CD8 T cells and reject tumor in preclinical models (16). The gene discussed is CD8A; the disease is neoplasm.